When was Endogenex founded?

Endogenex was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Endogenex located?

Endogenex is headquartered in Plymouth, United States. It is registered at 151 Cheshire Ln N #400, Plymouth, MN 55441.

How many employees does Endogenex have?

As of Mar 01, 2026, the latest employee count at Endogenex is 10 - 49.

Is Endogenex a funded company?

Endogenex is a funded company, having raised a total of $190M across 7 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Feb 13, 2018.

When was the latest funding round of Endogenex?

Endogenex's latest funding was a $***** Series C round on Mar 25, 2026, with participation from 1 investor. Its primary sector is Diabetes. In United States, the Diabetes sector has seen $819M in funding in 2026 to date.

Where does Endogenex rank among its competitors?

Endogenex ranks 1st amongst 5 active competitors, of which 2 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Endogenex, which secured $50M in Mar, 2026.

Who are the top competitors of Endogenex?

Endogenex's top competitors include Metavention, MetaCure and Cell MedX. Among them, Endogenex secured the most recent funding round in March, 2026.

Endogenex - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of medical devices for the treatment of Type 2 diabetes. The company has developed a novel therapy that utilizes pulsed electric fields to promote regeneration of the duodenal mucosa for improvement in glycemic control in patients with Type 2 diabetes.

Website: www.endogenex.com/
Social
Email ID: *****@endogenex.com
Phone Number: +1 **********
Registered Address: 151 Cheshire Ln N #400, Plymouth, MN 55441

Key Metrics

Founded Year

2017

Location

Plymouth, United States

Stage

Series C

Total Funding

$190M in 7 rounds

Latest Funding Round

Series C, Mar 25, 2026, $*****

Investors

FDA & 9 more

Ranked

1^st among 5 active competitors

Employee Count

10 - 49 as on Mar 01, 2026

Similar Companies

Metavention & 5 more

View Endogenex's full profile

Endogenex is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Endogenex, Inc. CIN: 35-2587644 , United States, Active	Mar 02, 2017	-	15 (As on Dec 31, 2021)	-

Endogenex has raised a total funding of $190M over 7 rounds. Its first funding round was on Feb 13, 2018. Its latest funding round was a Series C round on Mar 25, 2026 for $*****. 1 investor participated in its latest round. Endogenex has 10 institutional investors.

Here is the list of recent funding rounds of Endogenex:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 25, 2026	9036746	Series C	2688496	4020269	4422992	4982285
Jun 13, 2024	4488260	Series C	9069482	2703822	7106315	Intuitive & 3 more
Oct 11, 2023	2740757	Series B	3636378	6112358	4943547	8348778

Access funding benchmarks and valuations. Sign up today!

View details of Endogenex's funding rounds and investors

The founders of Endogenex is Michael Brenzel.

Here are the details of Endogenex's key team members:

Michael Brenzel: Co-Founder & CTO of Endogenex. They serve on the board of 1 company.
Contact Info: 1 email address

Endogenex's Board of Directors

Endogenex's board has 11 active members. Michael Brenzel, Gerald Brunk, ROBERT KUKUJLAN, James Eadie, M.D., Robert Kukuljan, Juliet Bakker, John Deedrick, PAUL HINDRICHS, Stacey Pugh, Jeffrey Terrell and James Eadie are independent board members.

Here is the list of Endogenex's board of directors:

Name	Type	Representing	Status	Duration
Michael Brenzel	Independent board member	-	Current	7y 9m
zdvp{qi	Independent board member	-	Current	2y 8m
muagnwb	Independent board member	-	Current	5y 2m
rinmprq	Independent board member	-	Current	7y 6m
ihfwlno	Independent board member	-	Current	6y 8m
cfltvea	Independent board member	-	Current	6y 6m
tvevtvh	Independent board member	-	Current	5y 2m
u{axrtn	Independent board member	-	Current	1y 3m
xdcfbzr	Independent board member	-	Current	4y 2m
canhybr	Independent board member	-	Current	6y 7m
brlc{gd	Independent board member	-	Current	8y 2m

View details of Endogenex's Founder profiles and Board Members

Endogenex's employee count trend

Endogenex has 10 - 49 employees as of Mar 26. Here is Endogenex's employee count trend over the years:

Uncover Endogenex's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Endogenex include Metavention, MetaCure and Cell MedX. Here is the list of Top 10 competitors of Endogenex, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Endogenex 2017, Plymouth (United States), Series C	Developer of medical devices for the treatment of Type 2 diabetes	$190M	Longitude Capital, FDA & 8 others	56/100
2nd	Metavention 2011, Eden Prairie (United States), Series C	Developer offering electrotherapy for treating diabetes	$65M	New Enterprise Associates, Versant Ventures ... & 5 others	38/100
3rd	MetaCure 2003, Kfar Saba (Israel), Deadpooled	Implantable Gastric electrical stimulator	$20M	Morningside, Hobart Group	32/100
4th	Cell MedX 2014, Carson City (United States), Public	Bio-signal generating device for diabetes therapy and pain management	-	-	28/100
5th	Biomolecular 2009, Boca Raton (United States), Unfunded	Provider of non-invasive medical technology for producing insulin and treat diabetes	-	-	24/100
6th	Bioflex Laser Therapy 1993, Toronto (Canada), Unfunded	Portfolio of laser devices for musculoskeletal and traumatic problems	-	-	22/100
7th	BetaStim 2006, Herzliya (Israel), Deadpooled	Implantable duodenal neuro-stimulator for the treatment of obese type 2 diabetes	-	-	15/100